MA44557B1 - Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer - Google Patents
Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrerInfo
- Publication number
- MA44557B1 MA44557B1 MA44557A MA44557A MA44557B1 MA 44557 B1 MA44557 B1 MA 44557B1 MA 44557 A MA44557 A MA 44557A MA 44557 A MA44557 A MA 44557A MA 44557 B1 MA44557 B1 MA 44557B1
- Authority
- MA
- Morocco
- Prior art keywords
- vaccine
- buffer
- stable
- acid
- low
- Prior art date
Links
- 229940124859 Rotavirus vaccine Drugs 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 229940069428 antacid Drugs 0.000 abstract 1
- 239000003159 antacid agent Substances 0.000 abstract 1
- 230000001458 anti-acid effect Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
L'invention concerne un vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer. Le vaccin est disponible sous la forme de doses d'un volume inférieur à 1 ml par dose destinées à être administrées par voie orale, et ne contient pas de tampon. Le vaccin ne nécessite pas d'administration, avant ou après l'administration par voie orale du vaccin au patient, d'anti-acide qui viserait à neutraliser l'acidité gastrique. Le vaccin montre une diminution de la ch
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641020675 | 2016-06-16 | ||
| PCT/IN2017/050237 WO2017216808A1 (fr) | 2016-06-16 | 2017-06-13 | Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA44557A1 MA44557A1 (fr) | 2020-01-31 |
| MA44557B1 true MA44557B1 (fr) | 2021-11-30 |
Family
ID=60664101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA44557A MA44557B1 (fr) | 2016-06-16 | 2017-06-12 | Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11351245B2 (fr) |
| EP (1) | EP3471768B1 (fr) |
| JP (1) | JP7108549B2 (fr) |
| KR (3) | KR20190020046A (fr) |
| CN (1) | CN109562159B (fr) |
| AU (1) | AU2017285408B2 (fr) |
| CA (1) | CA3027703A1 (fr) |
| CO (1) | CO2019000078A2 (fr) |
| EA (1) | EA201990027A1 (fr) |
| GB (1) | GB2566244B (fr) |
| IL (1) | IL263740B2 (fr) |
| JO (1) | JOP20180124B1 (fr) |
| MA (1) | MA44557B1 (fr) |
| MX (1) | MX2018015469A (fr) |
| MY (1) | MY198419A (fr) |
| PH (1) | PH12018502650B1 (fr) |
| SG (2) | SG10202012281TA (fr) |
| TN (1) | TN2018000436A1 (fr) |
| UA (1) | UA124430C2 (fr) |
| WO (1) | WO2017216808A1 (fr) |
| ZA (1) | ZA201900176B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220370595A1 (en) * | 2016-06-16 | 2022-11-24 | Bharat Biotech International Limited | Buffer Free, Acid Stable Low Dose Volume Rotavirus Vaccine |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6616931B1 (en) | 1996-09-26 | 2003-09-09 | Merck & Co., Inc. | Rotavirus vaccine formulations |
| US6403098B1 (en) | 1996-09-26 | 2002-06-11 | Merck & Co., Inc. | Rotavirus vaccine formulations |
| DE69738271T2 (de) | 1996-09-26 | 2008-08-28 | Merck & Co., Inc. | Rotavirus-impfstoff |
| EP0878541A4 (fr) * | 1996-10-18 | 2001-10-17 | Univ Osaka Res Found | Antigenes de rotavirus, vaccins et medicaments servant a diagnostiquer l'infection par rotavirus et leurs procedes de preparation |
| CN100387300C (zh) | 1998-07-28 | 2008-05-14 | 由卫生与公众服务部代表的美利坚合众国 | 多价人-牛轮状病毒疫苗 |
| SK287261B6 (sk) | 1999-08-17 | 2010-04-07 | Smithkline Beecham Biologicals S.A. | Oslabená ľudská rotavírusová populácia, spôsob jej výroby, vakcínový prostriedok s jej obsahom a jej použitie |
| JP2005038411A (ja) | 2003-06-30 | 2005-02-10 | Sony Corp | 機器認証情報組込システム、端末機器、機器認証情報処理方法、機器認証情報処理プログラム、提供サーバ、機器認証情報提供方法、機器認証情報提供プログラム、及び記憶媒体 |
| GB0503337D0 (en) | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
| GB0516944D0 (en) * | 2005-08-17 | 2005-09-28 | Glaxosmithkline Biolog Sa | Vaccine |
| AU2007251122B2 (en) | 2006-05-12 | 2013-01-10 | Bharat Biotech International Limited | A composition useful as a vaccine |
| CN101638638A (zh) * | 2008-07-29 | 2010-02-03 | 辽宁依生生物制药有限公司 | 人猪重配轮状病毒 |
| RU2553331C2 (ru) * | 2009-07-13 | 2015-06-10 | Бхарат Байотек Интернэшнл Лимитед | Композиция, применимая в качестве ротавирусной вакцины, и способ ее получения |
| CN103747800A (zh) * | 2011-04-28 | 2014-04-23 | 国际医学基金会 | 液体疫苗制剂 |
| CN110227152A (zh) * | 2012-04-23 | 2019-09-13 | 巴拉特生物技术国际有限公司 | 轮状病毒疫苗组合物及其制备方法 |
-
2017
- 2017-06-12 MA MA44557A patent/MA44557B1/fr unknown
- 2017-06-13 MY MYPI2018002561A patent/MY198419A/en unknown
- 2017-06-13 SG SG10202012281TA patent/SG10202012281TA/en unknown
- 2017-06-13 MX MX2018015469A patent/MX2018015469A/es unknown
- 2017-06-13 US US16/310,039 patent/US11351245B2/en active Active
- 2017-06-13 KR KR1020197001395A patent/KR20190020046A/ko not_active Ceased
- 2017-06-13 JP JP2018565803A patent/JP7108549B2/ja active Active
- 2017-06-13 PH PH1/2018/502650A patent/PH12018502650B1/en unknown
- 2017-06-13 CN CN201780050188.2A patent/CN109562159B/zh active Active
- 2017-06-13 EA EA201990027A patent/EA201990027A1/ru unknown
- 2017-06-13 KR KR1020227015137A patent/KR20220063302A/ko not_active Ceased
- 2017-06-13 AU AU2017285408A patent/AU2017285408B2/en active Active
- 2017-06-13 CA CA3027703A patent/CA3027703A1/fr active Pending
- 2017-06-13 KR KR1020237028691A patent/KR102792978B1/ko active Active
- 2017-06-13 EP EP17812897.1A patent/EP3471768B1/fr active Active
- 2017-06-13 TN TNP/2018/000436A patent/TN2018000436A1/en unknown
- 2017-06-13 WO PCT/IN2017/050237 patent/WO2017216808A1/fr not_active Ceased
- 2017-06-13 IL IL263740A patent/IL263740B2/en unknown
- 2017-06-13 GB GB1900562.8A patent/GB2566244B/en active Active
- 2017-06-13 SG SG11201811188TA patent/SG11201811188TA/en unknown
- 2017-06-13 UA UAA201900420A patent/UA124430C2/uk unknown
-
2018
- 2018-12-16 JO JOJO/P/2018/0124A patent/JOP20180124B1/ar active
-
2019
- 2019-01-08 CO CONC2019/0000078A patent/CO2019000078A2/es unknown
- 2019-01-10 ZA ZA2019/00176A patent/ZA201900176B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ780890A (en) | Pharmaceutical compositions comprising meloxicam | |
| CY1122792T1 (el) | Παραγωγα μονο- ή δισυποκατεστημενης ινδολης ως αναστολεις αναδιπλασιασμου δαγκειου ιου | |
| UA124347C2 (uk) | Циклічна динуклеотидна сполука | |
| EA201790568A1 (ru) | Применение двойного агониста рецепторов glp-1/глюкагона пролонгированного действия для лечения неалкогольной жировой болезни печени | |
| EA201792592A1 (ru) | Фармацевтические препараты, содержащие тенофовир и эмтрицитабин | |
| EP4233892A3 (fr) | Formulation stable anti-ifnar1 | |
| CA3030422C (fr) | Excipients stabilisants pour formulations de proteines therapeutiques | |
| EA201792591A1 (ru) | Фармацевтические препараты | |
| ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| CL2019003533A1 (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
| CY1124635T1 (el) | Ξηρες φαρμακευτικες συνθεσεις που περιεχουν νανοσωματιδια ενεργου παραγοντα δεσμευμενα σε σωματιδια φορεα | |
| EA201792144A1 (ru) | Стабильный препарат для парентерального введения тапентадола | |
| MX2017015202A (es) | Formulaciones liquidas de celecoxib para administracion oral. | |
| JP2018506533A5 (fr) | ||
| JP2016534062A5 (fr) | ||
| EA201990668A1 (ru) | Фармацевтическая композиция, содержащая антагонист минералокортикоидных рецепторов, и ее применение | |
| MA44557A1 (fr) | Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer | |
| FI3137094T3 (fi) | Alzheimerin taudin (ad) hoitaminen ja ehkäiseminen | |
| EA201890929A1 (ru) | Низкие дозировки композиций дипиридамола для перорального приема и их использование | |
| WO2014193269A3 (fr) | Médicament à base de diindolylméthane et son utilisation pour traiter la grippe et les infections virales respiratoires | |
| MX393290B (es) | Composicion para el tratamiento de la osteoartritis | |
| EA202091127A1 (ru) | Фармацевтические композиции, включающие сафинамид | |
| CY1120282T1 (el) | Φαρμακευτικη συνθεση κιτρικης σιλδεναφιλης με την μορφη ενος εναιωρηματος για εκ του στοματος χρηση | |
| ZA202200330B (en) | Pharmaceutical composition of imatinib |